Skip to main content

JANE STREET GROUP, LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in DSGN

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,105,516
-$1,019,165 QoQ
Shares Held
103,902
-54.1% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Derivatives in DSGN

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$102,242
PutShares
10,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,248,975,671 across 317 Biotechnology names. DSGN ranks #116 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DSGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,105,516 103,902
2025-12-31 $102,242 10,900
2025-12-31 $2,124,681 226,512
2025-09-30 $887,281 117,833
2025-06-30 $104,735 31,079
2025-03-31 $69,962 18,125
2024-09-30 $129,135 24,003
2024-06-30 $193,981 57,905
2023-12-31 $144,936 54,693
2023-09-30 $69,343 29,383
2023-06-30 $210,004 33,334
2023-03-31 $1,169,717 202,724
2022-06-30 $177,870 12,705